Rezūm Water Vapour Therapy

What is Rezūm therapy?

Rezūm Therapy is an in-office treatment for men looking to treat BPH, not just the symptoms. It uses natural water vapor to reduce the size of the prostate and provide lasting symptom relief from BPH without invasive surgery or the potential side effects of prescription drugs. Clinical studies support that Rezūm Therapy relieves BPH symptoms safely and effectively, eliminating the need for BPH medications while also preserving sexual function. It helps most men see symptom improvement within
a few weeks and return to regular activities within a few days after treatment.

Who may benefit from Rezūm Therapy?

Clinical studies show that Rezūm Therapy provides significant lasting, improvement in symptoms and quality of life. It may be an option for those who have given up on watchful waiting and lifestyle changes, men who are dissatisfied with, have stopped or don’t want to start taking BPH medications, and men not interested in other minimally invasive or surgical BPH procedures. Rezūm Therapy removes excess prostate tissue with water vapor, thereby treating the disease while also relieving symptoms and preserving sexual function.

How is Rezūm Therapy performed?

The procedure takes place usually as a day surgery procedure and does not require general anesthesia. During each 9-second treatment, natural water vapor is released throughout the targeted prostate tissue. When the steam contacts the tissue and turns back into water, all the stored energy is released, killing the excess prostate cells. Over time, the body’s natural healing response absorbs the dead cells and shrinks the prostate. With the extra tissue removed, the urethra opens, reducing BPH symptoms. Depending on the size of the prostate, the number of water vapor treatments vary.

What are the risks of Rezūm Therapy?

All treatments have inherent and associated risks. The Rezūm System is intended to relieve symptoms and obstructions, and reduce prostate tissue associated with BPH. It is indicated for men ≥ 50 years of age with a prostate volume 30cm3 ≤ 80cm3 . The Rezūm System is also indicated for treatment of prostate with hyperplasia of the central zone and/or a median lobe.

Potential risks include but are not limited to painful urination (dysuria), blood in the urine (hematuria), blood in the semen (hematospermia), decrease in ejaculatory volume, suspected urinary tract infection (UTI), and urinary frequency, retention or urgency. Patients should talk with their doctor about benefits and risks before moving forward with any treatment option.

Has Rezūm Therapy been clinically tested?

Rezūm Therapy has undergone extensive clinical trials to evaluate the safety and efficacy of the treatment. It is now included in the American Urological Association’s BPH treatment guidelines and has four-year follow-up data showing its ability to treat prostates with hyperplasia of the central zone, lateral lobe and/or median lobe. Over the four years, the trial showed a surgical retreatment rate of only 4.4% and no new adverse events noted between years three and four.